Article Details

GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical Trial

Retrieved on: 2021-04-08 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical Trial. View article details on HISWAI: https://www.prnewswire.com/news-releases/gt-biopharma-announces-enrollment-of-patient-10-in-gtb-3550-trike-phase-iii-clinical-trial-301264767.html

Excerpt

BEVERLY HILLS, Calif., April 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up